Today: 9 June 2026
Bitcoin Price Today: BTC Slips Below $75,000 as Iran Jitters and Oil Spike Hit Risk Assets
20 April 2026
1 min read

Bitcoin Price Today: BTC Slips Below $75,000 as Iran Jitters and Oil Spike Hit Risk Assets

London, April 20, 2026, 10:07 BST

Bitcoin hovered close to $74,731 on Monday, after whipping between $73,831 and $76,209 earlier in the day. The token slipped roughly 0.7% from its prior close. Ether—No. 2 by market cap—was trading near $2,295, also posting a decline for the day.

This shift is notable: bitcoin’s been trading more like a risk-on asset than a haven lately, with investors quick to unload as anxiety creeps in. European stocks slipped, Brent crude surged 5.3% to $95.19 a barrel, and optimism around a lasting U.S.-Iran ceasefire faded, leaving broader markets decidedly wary.

Fresh tensions flared after the U.S. seized an Iranian cargo ship, prompting the dollar to climb, according to Reuters. Tehran indicated it would skip a second round of talks, adding to market jitters. Susannah Streeter, chief investment strategist at Wealth Club, pointed to “fresh worries” around the ceasefire’s stability, noting investors remain nervous. Reuters

The retreat followed just days after fresh money had begun trickling back into digital assets. CoinShares’ weekly update recorded $1.1 billion in inflows for digital-asset investment products last week—the biggest tally since early January. Bitcoin products took in $871 million of that total. Research head James Butterfill pointed to a rebound in risk appetite, citing hopes for a ceasefire and cooler U.S. inflation and spending figures.

Late last week, optimism wavered as price action told the story. Bitcoin climbed to $75,375 on Friday, briefly buoyed by what looked like a cooling in Middle East tensions. But Dessislava Ianeva at Nexo Dispatch cautioned that the move was tied to geopolitics, describing the rally as still “fragile.” Barron’s

Bitcoin wasn’t the only one slipping on Monday. Ether, XRP, and solana all ticked down in earlier sessions, pointing to a wider pullback across crypto—not just a bitcoin story.

Still, institutional momentum in crypto remains. Charles Schwab announced Thursday it’s set to introduce spot crypto trading within weeks. Goldman Sachs, for its part, filed for its debut bitcoin ETF just days after Morgan Stanley unveiled a spot bitcoin fund of its own. But as Morningstar’s Bryan Armour pointed out, Goldman’s offering might face “a hard sell” — volatility and downside risk are tough hurdles. Reuters

Bitcoin could be at the mercy of macro trends once more. Citi’s Alex Saunders highlighted the $70,000 mark as a key threshold last month, warning that the bank’s recession scenario still puts bitcoin down at $58,000 if conditions sour further.

That’s part of the reason traders keep hovering around the mid-$70,000s. As MarketWatch pointed out last week, analysts have zeroed in on $75,200 as a major resistance point. Even after bitcoin’s rally this month, it’s still down over 40% from the October 2025 high above $126,000.

Stock Market Today

  • Proxy Adviser Supports Nanoco Group's Plan to Delist from LSE
    June 9, 2026, 9:17 AM EDT. Nanoco Group PLC, a nanotechnology firm, announced that independent proxy adviser Glass Lewis has recommended shareholders approve the company's resolution to delist from the London Stock Exchange (LSE). The move signals a significant shift for Nanoco, potentially changing its trading and regulatory environment. Shareholder approval for such a resolution typically permits a company to withdraw its shares from public exchange trading, often to pursue private ownership or alternative funding routes. This development follows Nanoco's strategic review and may impact investor access and share liquidity. The recommendation by Glass Lewis adds weight to the proposal ahead of the upcoming shareholder vote.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Redwire Stock Faces Fresh Selling Pressure as Major Holders File New Sales After $20 Million Marine Corps Order
Previous Story

Redwire Stock Faces Fresh Selling Pressure as Major Holders File New Sales After $20 Million Marine Corps Order

Boeing Pushes Chinook Drone-Swarm Vision as Commercial Jet Recovery Faces Earnings Test
Next Story

Boeing Pushes Chinook Drone-Swarm Vision as Commercial Jet Recovery Faces Earnings Test

Go toTop